Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Dow
Julphar
Chubb
McKesson
Cerilliant
Cantor Fitzgerald
Chinese Patent Office
Express Scripts

Generated: April 19, 2018

DrugPatentWatch Database Preview

DIURIL Drug Profile

« Back to Dashboard

Which patents cover Diuril, and when can generic versions of Diuril launch?

Diuril is a drug marketed by Oak Pharms Akorn and Salix Pharms and is included in two NDAs.

The generic ingredient in DIURIL is chlorothiazide. There are forty-two drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the chlorothiazide profile page.
Drug patent expirations by year for DIURIL
Pharmacology for DIURIL
Ingredient-typeThiazides
Drug ClassThiazide Diuretic
Physiological EffectIncreased Diuresis
Medical Subject Heading (MeSH) Categories for DIURIL
Synonyms for DIURIL
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-, 1,1-dioxide, monosodium salt
6-Chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide, 1,1-dioxide, monosodium salt
7085-44-1
C7H5ClN3O4S2.Na
CHEMBL1200616
CHLOROTHIAZIDE SODIUM
Chlorothiazide sodium (USP)
Chlorothiazide sodium [USAN:USP]
Chlorothiazide sodium [USAN]
CPIWHAFLBZQYLQ-UHFFFAOYSA-N
D03471
Diuril sodium
DTXSID00221091
EINECS 230-387-3
HE061402
HE382052
LS-176845
Lyovac diuril
SN86FG7N2K
SODIUM 6-CHLORO-1,1-DIOXO-7-SULFAMOYL-2H-1??,2,4-BENZOTHIADIAZIN-2-IDE
Sodium diuril
UNII-SN86FG7N2K

US Patents and Regulatory Information for DIURIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Oak Pharms Akorn DIURIL chlorothiazide sodium INJECTABLE;INJECTION 011145-005 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Oak Pharms Akorn DIURIL chlorothiazide TABLET;ORAL 011145-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Salix Pharms DIURIL chlorothiazide SUSPENSION;ORAL 011870-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Oak Pharms Akorn DIURIL chlorothiazide TABLET;ORAL 011145-004 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Citi
Johnson and Johnson
Daiichi Sankyo
Boehringer Ingelheim
Cerilliant
Dow
Fish and Richardson
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.